Eye­ing big ther­a­peu­tic push, Gink­go bags $290M to build a cell pro­gram­ming em­pire

Gink­go Bioworks is on a roll. Days af­ter pub­li­ciz­ing a plan to nur­ture new star­tups via part­ner­ships with ac­cel­er­a­tors Y Com­bi­na­tor and Petri, the Boston biotech says it has raised an­oth­er $290 mil­lion for its cell pro­gram­ming plat­form to reach fur­ther and wider.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER